This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels

Thursday 25 May 2023

Commercial Transactions: What Are Killing Commercial Deals?

Reinvigorate Your Commercial Agreements And Discover Practical Tips To Drive Success Across Licensing, M&A, Joint Ventures and Investments.

Tools and Techniques For Effective Commercial Transactions

Transaction Trends and Deal Landscape in the Life Sciences Sector:

  • Hot Investment Sectors In The Life Science Sector
  • Update On Deal Structures, Spin offs, and Cross-Border Deals
  • Access To Capital Through New Financial Vehicles And Their Impact On Transactions
  • How Is Competition Between Pharma Companies And Institutional Investors For Biotech Platforms Evolving?

Take Away Expert Advice On:

  • Managing Delays And Costs Resulting From Foreign Direct Investment Screening In US and EU
  • Structuring Contracts To Minimise Risk For R&D Agreements And Licensing Of IP
  • How To Circumnavigate Antitrust Risk For Transactions And Filings
  • Key Market Insight: What Are Killing Commercial Deals?

Drive Success In Your Commercial Agreements:

  • Constructing Value For Platform Technology In IP Licensing Negotiations
  • New Developments And Risk Management In Digital Data Deals
  • Discussing Challenging Risks In License Collaboration, True JVs, M&A and Investment Deals
  • How To Balance Antitrust Considerations With Commercial Reasons To Share Information